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Microbe: Are We Ready for the
Next Plague? by Alan Zelicoff and
Michael Bellomo is a comprehensive,
yet succinct, account of the threat to
public health posed by microbial
pathogens. What distinguishes this
book from the surfeit of recent books
hyping the threat of bioterrorism are
its balanced perspective and elucida-
tion of naturally emerging disease
threats, such as severe acute respirato-
ry syndrome (SARS) or West Nile
virus, as exotic entities requiring a
rapid and effective response; Mother
Nature is quite the bioterrorist herself.
Early recognition that an event has
occurred is key to containment of the
nascent epidemic. 
The authors provide sufficient
basic science background to bring the
uninitiated up to speed on a variety of
exotic and recently introduced
microbes in engagingly titled chapters
such as “The Birds that Fell from the
Sky” (West Nile), “Corona of Death”
(SARS), and “Something in the
Water” (Cryptosporidium). In addi-
tion, they describe hantavirus pul-
monary syndrome, mad cow disease,
and Legionnaires’ disease in the con-
text of recent public health emergen-
cies. The authors also explain why
both smallpox and anthrax are more
than abstract concerns as agents of
bioterrorism, on the basis of
weaponization history, intrinsic attrib-
utes, and realistic scenarios. An
account of the 1970 smallpox out-
break, which occurred in Aralsk,
Kazakhstan, as a consequence of open
air testing of a smallpox weapon by
the Soviets is an eye-opener; there
should be no doubts about capability
and intent after reading this story. 
The scenarios are well chosen and
informative; they highlight the impor-
tance of early recognition that “some-
thing has happened” and breaking the
disease cycle close to the index case.
The unifying theme of the book is the
importance of syndrome-based sur-
veillance in achieving this goal. The
authors dismiss BIOWATCH (air-
monitoring devices to detect and iden-
tify microbes in aerosol clouds) as a
well-intended but expensive “work in
progress,” to put it charitably.
BIOSENSE is a national surveillance
system that they say has not been
implemented in any substantive way. I
reluctantly find myself in agreement
with these assessments and receptive
to their suggestions to implement an
emerging diseases reporting system
based on syndromic reporting. 
Healthcare providers recognize
syndromes, not microbial diseases.
How long did it take to recognize
monkeypox in 2003? The hantavirus
associated with lethal pulmonary syn-
drome in New Mexico in 1993 was
recognized only when the pattern
emerged among previously healthy
young adults living in rustic condi-
tions on a Navajo reservation. The
authors describe a product they dub
Syndromic Reporting Information
System (SYRIS) as a “beta test” prod-
uct that has been deployed on a limit-
ed, regional basis and promises to
provide a near instantaneous map of
syndromic reports and to comply with
all Centers for Disease Control and
Prevention requirements for electron-
ic reporting systems. Like most good
ideas, simplicity is central to the
SYRIS concept; it is likely to succeed
because participating doctors, nurses,
and veterinarians (most of the exotic
pathogens are zoonoses) can report
syndromic occurrences in 15 seconds
or less and will be rewarded with
instantaneous feedback and tailored
reports and alarms. While this section
does read a bit like an infomercial, the
concept is sound and worthy of seri-
ous consideration by public health
officials and policy makers. This book
is the best of its genre and is recom-
mended for anyone interested in
understanding and managing the risks
associated with emerging microbial
threats.  
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As we enter the third decade of the
AIDS pandemic, numerous texts
explore the many aspects of AIDS and
its consequences. Mayer and Pizer’s
premise is that AIDS has transformed
many of the disciplines that it has
touched. For the most part, this well-
written volume supports their thesis.
The authors, all established
researchers, tackle many of the major
issues, including virology, immunolo-
gy, vaccines, microbicides, and sexu-
ally transmitted diseases, as well asBOOK REVIEWS
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Correction: Vol. 11, No. 10
In “Methicillin-resistant Staphylococcus aureus Necro-
tizing Pneumonia,” by Monica Monaco et al., an error
occurred on page 1647, in the first full sentence of the third
column. The sentence should read “On day 3 of admission,
antimicrobial drug therapy was changed to linezolid (600
mg 2 times a day).”
The corrected text appears in the online article at
http://www.cdc.gov/ncidod/EID/vol11no10/05-0776.htm
We regret any confusion this error may have caused.
the global impact of HIV/AIDS. Each
chapter provides a well-referenced
overview of its topic with many refer-
ences as recent as 2003.
One of the real strengths of this
book is a chapter on quantitative sci-
ence that explores not only the history
of HIV clinical trials, but also the
design and importance of clinical tri-
als in general. This chapter should be
required reading for those considering
clinical research in HIV. The chapters
on Africa and Asia ably contrast the
differences in these areas of highest
prevalence. Another strength is the
discussion of HIV in correctional
facilities and the challenge of caring
for this population, including their
coexisting conditions and illicit drug
use. Lastly, the discussion of the eco-
nomics of AIDS is especially wel-
come in this era of efforts to increase
access to drugs worldwide. 
Overall, this book fills a valuable
niche. A relatively concise text, it
reviews many aspects of HIV with a
focus on how each topic has evolved
over the years. Afew tables are small,
but overall the diagrams and charts
are clear and legible. This book would
be of interest to infectious disease fel-
lows, HIV caregivers, and those
involved in public health and health
policy. I heartily recommend this
book and plan to keep it handy for
future reference.
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During the past 2 decades, the sci-
entific landscape of tickborne dis-
eases has changed remarkably. In part
because of advances in molecular
biology, more than 10 new rickettsial
diseases, several ehrlichial diseases,
and novel agents of Borrelia and
Babesia genera have been recognized.
This renaissance of interest in tick-
borne infections benefits from
advances in molecular phylogenetics
and diagnostics, immunology, and
informatics that provide tantalizing
insights into the complexities of vec-
torborne infection. Tick-Borne
Diseases of Humans is a well-refer-
enced textbook that encompasses
these new insights in vector biology
and reviews the emerging epidemiolo-
gy and clinical science of these dis-
eases as they occur across the globe.
The editors’goal of providing a “com-
prehensive” resource is admirably ful-
filled.
The book, consisting of 20 chap-
ters by 40 contributors, is divided into
3 sections. The first section includes
excellent reviews of tick biology and
systematics, tick-pathogen interac-
tions, host responses, and vector man-
agement. This section provides a
superb overview. While thorough and
up-to-date, occasional redundancy
occurs between chapters by different
authors that could have been stream-
lined with additional editing. A con-
cise and well-written chapter on the
clinical approach to diagnosis and
management of these diseases also
seems misplaced; it would fit in better
at the start of the next section.
Section 2 of the book includes
summaries of major and lesser known
tickborne infections. These chapters
each provide detailed information on
specific vectors and pathogens and on
the epidemiology and clinical charac-
teristics of the diseases they cause.
While the description of the molecu-
lar biology and vector ecology of
these infections is generally excellent,
the clinical discussions often lack the
nuance and detail of current infectious
diseases texts. Nevertheless, each
chapter provides current and well-
referenced information on disease
manifestations, diagnosis, and treat-
ment. Several chapters, i.e., those on
Correction: Vol 11, No. 8
In “Laboratory Exposures to Brucellae and Implications
for Bioterrorism” by Pablo Yagupsky and Ellen Jo Baron,
an error occurred in the dosage for rifampin prophylaxis. 
On page 1184, first column, first paragraph, the correct
dosage of rifampin is 600 mg once daily.
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